Dr. Reem Miari

Founder & CEO

Founder & CEO, Dreem Innovations | Director, Gene Therapy Global

Dr. Reem Miari is a distinguished leader in the fields of gene therapy, exosome technology, and cancer research, with over 27 years of experience in the biotech industry. As the Director of Gene Therapy Global, she is dedicated to making advanced cell and gene therapies accessible worldwide. She is also the Founder and CEO of Dreem Innovations, a cutting-edge company specializing in viral vector production, plasmid production, and exosome-based research.

Dr. Miari holds a Ph.D. in Molecular Genetics from the University of Haifa, where she conducted groundbreaking research on microRNAs in head and neck cancer. She has led multiple clinical trials, translational research projects, and biotech innovations, with expertise spanning CAR T-cell therapy, immunotherapy, viral vector development, and regenerative medicine.

Throughout her career, Dr. Miari has held senior leadership roles in major biotech companies, including Orgenesis Inc., where she spearheaded global initiatives in gene therapy and viral vector development. She previously served as Head of Cell Therapy and Tissue Engineering at Galilee Medical Center, where she managed pioneering research in exosome-based treatments and regenerative medicine.

More Information

A named inventor on multiple patents and a published researcher in leading scientific journals, Dr. Miari has contributed extensively to the development of next-generation therapies for cancer, autoimmune diseases, and neurodegenerative disorders. She is also a sought-after biotech consultant, lecturer, and mentor, shaping the future of cell and gene therapy through education and innovation.

Driven by a passion for scientific excellence and translational impact, Dr. Miari continues to lead cutting-edge research that bridges the gap between innovation and patient care.